chrX-54470441-C-T

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_004463.3(FGD1):​c.676G>A​(p.Ala226Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00321 in 1,203,728 control chromosomes in the GnomAD database, including 8 homozygotes. There are 1,169 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0025 ( 0 hom., 99 hem., cov: 23)
Exomes 𝑓: 0.0033 ( 8 hom. 1070 hem. )

Consequence

FGD1
NM_004463.3 missense

Scores

2
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.0210
Variant links:
Genes affected
FGD1 (HGNC:3663): (FYVE, RhoGEF and PH domain containing 1) This gene encodes a protein that contains Dbl (DH) and pleckstrin (PH) homology domains and is similar to the Rho family of small GTP-binding proteins. The encoded protein specifically binds to the Rho family GTPase Cdc42Hs and can stimulate the GDP-GTP exchange of the isoprenylated form of Cdc42Hs. It also stimulates the mitogen activated protein kinase cascade leading to c-Jun kinase SAPK/JNK1 activation. Defects in this gene are the cause of the faciogenital dysplasia in Aarskog-Scott syndrome and a syndromatic form of X-linked cognitive disability. [provided by RefSeq, Jul 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), FGD1. . Gene score misZ 3.5183 (greater than the threshold 3.09). GenCC has associacion of gene with Aarskog-Scott syndrome, X-linked.
BP4
Computational evidence support a benign effect (MetaRNN=0.004192412).
BP6
Variant X-54470441-C-T is Benign according to our data. Variant chrX-54470441-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 95094.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-54470441-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00252 (281/111549) while in subpopulation AMR AF= 0.00653 (69/10573). AF 95% confidence interval is 0.00529. There are 0 homozygotes in gnomad4. There are 99 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 99 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FGD1NM_004463.3 linkuse as main transcriptc.676G>A p.Ala226Thr missense_variant 4/18 ENST00000375135.4 NP_004454.2 P98174A0A024R9Y5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FGD1ENST00000375135.4 linkuse as main transcriptc.676G>A p.Ala226Thr missense_variant 4/181 NM_004463.3 ENSP00000364277.3 P98174

Frequencies

GnomAD3 genomes
AF:
0.00252
AC:
281
AN:
111497
Hom.:
0
Cov.:
23
AF XY:
0.00294
AC XY:
99
AN XY:
33713
show subpopulations
Gnomad AFR
AF:
0.000457
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00653
Gnomad ASJ
AF:
0.000378
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000375
Gnomad FIN
AF:
0.00362
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00323
Gnomad OTH
AF:
0.00201
GnomAD3 exomes
AF:
0.00268
AC:
463
AN:
172713
Hom.:
1
AF XY:
0.00212
AC XY:
128
AN XY:
60305
show subpopulations
Gnomad AFR exome
AF:
0.000250
Gnomad AMR exome
AF:
0.00288
Gnomad ASJ exome
AF:
0.000814
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000221
Gnomad FIN exome
AF:
0.00460
Gnomad NFE exome
AF:
0.00383
Gnomad OTH exome
AF:
0.00371
GnomAD4 exome
AF:
0.00328
AC:
3581
AN:
1092179
Hom.:
8
Cov.:
32
AF XY:
0.00297
AC XY:
1070
AN XY:
359709
show subpopulations
Gnomad4 AFR exome
AF:
0.000304
Gnomad4 AMR exome
AF:
0.00265
Gnomad4 ASJ exome
AF:
0.00103
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000932
Gnomad4 FIN exome
AF:
0.00441
Gnomad4 NFE exome
AF:
0.00375
Gnomad4 OTH exome
AF:
0.00300
GnomAD4 genome
AF:
0.00252
AC:
281
AN:
111549
Hom.:
0
Cov.:
23
AF XY:
0.00293
AC XY:
99
AN XY:
33775
show subpopulations
Gnomad4 AFR
AF:
0.000456
Gnomad4 AMR
AF:
0.00653
Gnomad4 ASJ
AF:
0.000378
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000376
Gnomad4 FIN
AF:
0.00362
Gnomad4 NFE
AF:
0.00323
Gnomad4 OTH
AF:
0.00199
Alfa
AF:
0.00317
Hom.:
130
Bravo
AF:
0.00252
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00381
AC:
11
ESP6500AA
AF:
0.000523
AC:
2
ESP6500EA
AF:
0.00343
AC:
23
ExAC
AF:
0.00231
AC:
280

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 24, 2024- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJun 01, 2017- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 11, 2014- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 27, 2017This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
FGD1-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesFeb 28, 2020This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.77
T
BayesDel_noAF
Benign
-0.88
CADD
Benign
10
DANN
Uncertain
0.98
DEOGEN2
Benign
0.066
T
FATHMM_MKL
Benign
0.029
N
LIST_S2
Benign
0.65
T
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.0042
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-0.49
N
REVEL
Benign
0.036
Sift
Benign
0.19
T
Sift4G
Benign
0.78
T
Polyphen
0.012
B
Vest4
0.017
MVP
0.28
MPC
0.30
ClinPred
0.011
T
GERP RS
1.5
Varity_R
0.048
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138723423; hg19: chrX-54496874; API